top of page

4BIO Capital leads oversubscribed $33 Million Seed Financing of Cloverleaf Bio, Advancing Novel RNA-Based Cancer Therapeutics

Sep 8
3 min read
ARCHIVE
SEARCH BY TAGS
FOLLOW US
UK Private Capital_Member logo_Colour_(rgb)_LR.png
4BIO Capital is a trading name of 4BIO Partners LLP which is authorised and regulated by the Financial Conduct Authority (Reference Number 842764)
 
© 2015-2026 by 4BIO Partners LLP
bottom of page